Micron Technology Announces Upcoming Investor Events

BOISE, Idaho, May 07, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) announced today that company executives will participate in fireside chats at the following investor events:

• J.P. Morgan’s 52nd Annual Global Technology, Media and Communications Conference in Boston on Tuesday, May 21 at 6:10 a.m. Mountain time.
• Goldman Sachs’ Global Semiconductor Conference in New York on Thursday, May 30 at 6:20 a.m. Mountain time.

Live webcasts and subsequent replays of presentations can be accessed from Micron’s Investor Relations website at investors.micron.com/.

About Micron Technology, Inc.  
We are an industry leader in innovative memory and storage solutions transforming how the world uses information to enrich life for all. With a relentless focus on our customers, technology leadership, and manufacturing and operational excellence, Micron delivers a rich portfolio of high-performance DRAM, NAND and NOR memory and storage products through our Micron® and Crucial® brands. Every day, the innovations that our people create fuel the data economy, enabling advances in artificial intelligence and 5G applications that unleash opportunities — from the data center to the intelligent edge and across the client and mobile user experience. To learn more about Micron Technology, Inc. (Nasdaq: MU), visit micron.com.

© 2024 Micron Technology, Inc. All rights reserved. Information, products, and/or specifications are subject to change without notice. Micron, the Micron logo, and all other Micron trademarks are the property of Micron Technology, Inc. All other trademarks are the property of their respective owners.

Micron Media Relations Contact
Erica Pompen
Micron Technology, Inc.
+1 (408) 834-1873
[email protected]

Micron Investor Relations Contact
Satya Kumar
Micron Technology, Inc.
+1 (408) 450-6199
[email protected]

You May Also Be Interested In

• Popular stocks with increasing option volume: MU PLTR DELL INTC SPCX PCG AVGO SOFI MSTR NFLX IREN ORCL
• Trevi Therapeutics to Participate in Upcoming September Conferences
• FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis